M. J. SAADH, “SARS-COV-2 3CL-PROTEASE INHIBITORS AS ANTIVIRAL AGENT AGAINST COVID-19”, Int J App Pharm, vol. 14, no. 6, pp. 18–20, Nov. 2022.